{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": "OpEd", "lead_paragraph": null, "headline": {"main": "An Antidote to Overdose, in Time to Save Lives", "kicker": "Fixes"}, "abstract": "A lifesaving drug is starting to reach people who can use it promptly.", "print_page": null, "word_count": "1842", "_id": "537ccdde7988105f5f90c24c", "snippet": "A lifesaving drug is starting to reach people who can use it promptly.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://opinionator.blogs.nytimes.com/2014/05/21/an-antidote-to-overdose-in-time-to-save-lives/", "multimedia": [{"subtype": "wide", "url": "images/2014/05/21/opinion/21fixes-naloxone/21fixes-naloxone-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/05/21/opinion/21fixes-naloxone/21fixes-naloxone-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/05/21/opinion/21fixes-naloxone/21fixes-naloxone-articleLarge.jpg", "height": 372, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/05/21/opinion/21fixes-naloxone/21fixes-naloxone-articleLarge.jpg", "xlargeheight": "372"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/04/25/opinion/opinionator-pog-fixes/opinionator-pog-fixes-thumbStandard.gif", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/04/25/opinion/opinionator-pog-fixes/opinionator-pog-fixes-thumbStandard.gif", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Massachusetts", "name": "glocations", "rank": "1"}, {"value": "Naloxone (Drug)", "name": "subject", "rank": "2"}, {"value": "Drug Abuse and Traffic", "name": "subject", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Tina", "lastname": "ROSENBERG"}], "original": "By TINA ROSENBERG"}, "document_type": "blogpost", "pub_date": "2014-05-21T12:00:46Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "Former NFL lineman Jeremy Newberry often hobbled into the 49ers locker room on game days using a walking boot and crutches, then lined up behind as many as two dozen teammates, in his case to get a shot of the painkiller Toradol in the butt. Ten minutes later, he sprinted out of the tunnel and onto the field.", "headline": {"main": "Ex-Players Say Teams Gave Pain Pills 'Like Candy'", "print_headline": "Ex-Players Say Teams Gave Pain Pills 'Like Candy'"}, "abstract": null, "print_page": null, "word_count": "946", "_id": "537c382f7988101d46cbfd7c", "snippet": "Former NFL lineman Jeremy Newberry often hobbled into the 49ers locker room on game days using a walking boot and crutches, then lined up behind as many as two dozen teammates, in his case to get a shot of the painkiller Toradol in the butt. Ten...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/05/21/us/ap-fbn-nfl-drug-lawsuit.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-05-21T01:20:41Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "The Supreme Court issued a new stay on Wednesday to halt the execution of a Missouri death row inmate because his lawyers say he suffers from a rare health condition that could lead to undue suffering from a lethal injection.", "headline": {"main": "Supreme Court Stays Missouri Death Row Inmate's Execution", "print_headline": "Supreme Court Stays Missouri Death Row Inmate's Execution"}, "abstract": null, "print_page": null, "word_count": "376", "_id": "537c31227988101d46cbfd6f", "snippet": "The Supreme Court issued a new stay on Wednesday to halt the execution of a Missouri death row inmate because his lawyers say he suffers from a rare health condition that could lead to undue suffering from a lethal injection.", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2014/05/21/us/21reuters-usa-execution-missouri.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2014-05-21T00:51:25Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "Researchers found that smokers were more likely to quit if they used electronic cigarettes rather than therapies like nicotine patches or gum.", "headline": {"main": "Study Gives E-Cigarettes Edge in Helping Smokers Quit", "print_headline": "Study Gives E-Cigarettes Edge in Helping Smokers Quit"}, "abstract": "Study published in journal Addiction finds that smokers trying to quit are substantially more likely to succeed if they use electronic cigarettes than over-the-counter therapies; results offer encouraging but not definitive evidence in contentious debate about the increasingly popular smoking devices.", "print_page": "3", "word_count": "878", "_id": "537b7b3d798810409c9de749", "snippet": "Researchers found that smokers were more likely to quit if they used electronic cigarettes rather than therapies like nicotine patches or gum.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/05/21/health/study-gives-e-cigarettes-edge-in-helping-smokers-quit.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Smoking and Tobacco", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "E-Cigarettes", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Addiction (Journal)", "is_major": "Y", "rank": "8", "name": "organizations"}, {"value": "Medicine and Health", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "West, Robert", "is_major": "N", "rank": "7", "name": "persons"}, {"value": "Nicotine", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Sabrina", "lastname": "TAVERNISE"}], "original": "By SABRINA TAVERNISE"}, "document_type": "article", "pub_date": "2014-05-21T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "Opening another legal attack on the NFL over the long-term health of its athletes, a group of retired players accused the league in a lawsuit Tuesday of cynically supplying them with powerful painkillers and other drugs that kept them in the game but led to serious complications later in life.", "headline": {"main": "Ex-Players Sue NFL Over Use of Painkillers", "print_headline": "Ex-Players Sue NFL Over Use of Painkillers"}, "abstract": null, "print_page": null, "word_count": "917", "_id": "537b7f547988101d46cbfb28", "snippet": "Opening another legal attack on the NFL over the long-term health of its athletes, a group of retired players accused the league in a lawsuit Tuesday of cynically supplying them with powerful painkillers and other drugs that kept them in the game but...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/05/20/us/politics/ap-us-nfl-drug-lawsuit.html", "multimedia": [], "subsection_name": "Politics", "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-05-20T12:13:21Z", "section_name": "U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": "Business", "lead_paragraph": null, "headline": {"main": "The Curious Incident of Pfizer's 'Final' Offer for AstraZeneca", "kicker": "DealBook"}, "abstract": "Britain does not have as many takeover defenses as the United States, so it is puzzling why Pfizer did not make a full-fledged hostile bid for AstraZeneca.", "print_page": null, "word_count": "867", "_id": "537a2cee798810409c9de394", "snippet": "Britain does not have as many takeover defenses as the United States, so it is puzzling why Pfizer did not make a full-fledged hostile bid for AstraZeneca.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://dealbook.nytimes.com/2014/05/19/the-curious-incident-of-pfizers-final-offer-for-astrazeneca/", "multimedia": [{"subtype": "wide", "url": "images/2014/05/20/business/dbpix-dealprof/dbpix-dealprof-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/05/20/business/dbpix-dealprof/dbpix-dealprof-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/05/20/business/dbpix-dealprof/dbpix-dealprof-articleLarge.jpg", "height": 600, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/05/20/business/dbpix-dealprof/dbpix-dealprof-articleLarge.jpg", "xlargeheight": "600"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/05/20/business/dbpix-dealprof/dbpix-dealprof-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/05/20/business/dbpix-dealprof/dbpix-dealprof-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Dealbook", "keywords": [{"value": "United States", "name": "glocations", "rank": "2"}, {"value": "Great Britain", "name": "glocations", "rank": "1"}, {"value": "Pfizer Inc", "name": "organizations", "rank": "2"}, {"value": "AstraZeneca PLC", "name": "organizations", "rank": "1"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "3"}, {"value": "Federal Taxes (US)", "name": "subject", "rank": "2"}, {"value": "Taxation", "name": "subject", "rank": "4"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Steven"}], "original": "By STEVEN M. DAVIDOFF"}, "document_type": "blogpost", "pub_date": "2014-05-19T12:09:20Z", "section_name": "Business Day"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "Readers discuss the overuse of antibiotics in animals and how to promote development of a new generation of antibiotics.", "headline": {"main": "Rethinking How Antibiotics Are Used and Developed", "kicker": "Letters", "print_headline": "Rethinking How Antibiotics Are Used and Developed", "content_kicker": "Letters"}, "abstract": null, "print_page": "16", "word_count": "441", "_id": "53794bd67988100a0ee14663", "snippet": "Readers discuss the overuse of antibiotics in animals and how to promote development of a new generation of antibiotics.", "source": "", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/05/19/opinion/rethinking-how-antibiotics-are-used-and-developed.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Antibiotics", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "3", "name": "organizations"}], "byline": [], "document_type": "article", "pub_date": "2014-05-19T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "Readers discuss a doctor\u2019s call for expanded use of mind-body techniques for both financial and health reasons.", "headline": {"main": "Self-Care Strategies", "kicker": "Sunday Dialogue", "print_headline": "Self-Care Strategies", "content_kicker": "Sunday Dialogue"}, "abstract": null, "print_page": "10", "word_count": "1745", "_id": "5377aaae7988105a38431414", "snippet": "Readers discuss a doctor\u2019s call for expanded use of mind-body techniques for both financial and health reasons.", "source": "", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/05/18/opinion/sunday/self-care-strategies.html", "multimedia": [{"subtype": "wide", "url": "images/2014/05/18/sunday-review/0518LETTERS/0518LETTERS-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/05/18/sunday-review/0518LETTERS/0518LETTERS-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/05/18/sunday-review/0518LETTERS/0518LETTERS-articleLarge.gif", "height": 600, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/05/18/sunday-review/0518LETTERS/0518LETTERS-articleLarge.gif", "xlargeheight": "600"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/05/18/sunday-review/0518LETTERS/0518LETTERS-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/05/18/sunday-review/0518LETTERS/0518LETTERS-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Sunday Review", "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Preventive Medicine", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Alternative and Complementary Medicine", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Patient Protection and Affordable Care Act (2010)", "is_major": "N", "rank": "4", "name": "subject"}], "byline": [], "document_type": "article", "pub_date": "2014-05-18T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "Blog", "blog": [], "news_desk": "Science", "lead_paragraph": null, "headline": {"main": "Ask Well: AIDS and Truvada", "kicker": "Well", "print_headline": "Ask Well"}, "abstract": "Donald G. McNeil Jr. responds to reader questions about new recommendations to prevent H.I.V. infection with daily doses of the drug Truvada.", "print_page": null, "word_count": "938", "_id": "53768f977988107640d67a55", "snippet": "Donald G. McNeil Jr. responds to reader questions about new recommendations to prevent H.I.V. infection with daily doses of the drug Truvada.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2014/05/16/ask-well-aids-and-truvada/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Sexually Transmitted Diseases", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Antibiotics", "is_major": "Y", "rank": "1", "name": "subject"}], "byline": {"person": [{"qualifier": "JR", "firstname": "Donald", "middlename": "G.", "lastname": "MCNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. MCNEIL JR"}, "document_type": "blogpost", "pub_date": "2014-05-16T18:21:26Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "Federal health officials are lowering the starting dose of the popular sleeping aid drug Lunesta, due to risks of morning drowsiness that can impair driving ability and lead to injury.", "headline": {"main": "FDA Lowers Lunesta Dose Due to Next-Day Drowsiness", "print_headline": "FDA Lowers Lunesta Dose Due to Next-Day Drowsiness"}, "abstract": null, "print_page": null, "word_count": "326", "_id": "5374f95979881068df7c3522", "snippet": "Federal health officials are lowering the starting dose of the popular sleeping aid drug Lunesta, due to risks of morning drowsiness that can impair driving ability and lead to injury.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/05/15/us/politics/ap-us-lunesta-fda-action.html", "multimedia": [], "subsection_name": "Politics", "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-05-15T13:26:19Z", "section_name": "U.S."}], "meta": {"hits": 11, "offset": 0, "time": 74}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}